Madrigal Pharmaceutical 13G Filing Shows Janus Henderson Group PLC Holds 15.4% Stake In Company As Of September 29, 2023
Portfolio Pulse from Benzinga Newsdesk
Janus Henderson Group PLC has acquired a 15.4% stake in Madrigal Pharmaceuticals, according to a 13G filing with the SEC. The stake was acquired as of September 29, 2023.
October 10, 2023 | 5:10 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Janus Henderson Group PLC's acquisition of a 15.4% stake in Madrigal Pharmaceuticals could potentially influence the company's stock price.
The acquisition of a significant stake by a major investment group like Janus Henderson can influence the stock price of Madrigal Pharmaceuticals. This is due to the increased confidence in the company's prospects and the potential for increased demand for the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100